Join to view full profile
450 Brookline AveDana Farber Cancer InstituteBoston, MA 02215
Phone+1 617-632-3000
Dr. Hammerman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2011
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2008
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2015, 2017
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013-2015, 2017
Clinical Trials
Publications & Presentations
PubMed
- 9 citationsExpressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance.Jennifer L Cotton, Javier Estrada Diez, Vivek Sagar, Julie Chen, Michelle Piquet
Cancer Research. 2023-11-01 - 54 citationsSex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis.Katsuhiro Togami, Sun Sook Chung, Vikas Madan, Christopher A G Booth, Christopher M. Kenyon
Cancer Discovery. 2021-10-06 - 46 citationsInhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment.Hui Qin Wang, Iain Mulford, Fiona Sharp, Jinsheng Liang, Sema Kurtulus
Cancer Research. 2021-06-01
Journal Articles
- Author Correction: EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII InhibitorsPeter Hammerman, MD, Nature
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
- Exome and Genome Sequencing of Nasopharynx Cancer Identifies NF-κB Pathway Activating MutationsSimion I Chiosea, Peter S Hammerman, Jennifer R Grandis, Nicole G Chau, Nature
Press Mentions
Chutes & Ladders—J&J Science Chief Stoffels the Latest C-suite Leader to RetireOctober 15th, 2021- After 15 Years Helping Lead Early Cancer Research at Genentech, Malek Jumps Ship to Run Novartis' NIBR Oncology UnitOctober 14th, 2021
- Flagship Keeps Ex-FDA Commish Stephen Hahn Busy with Another CMO Gig; Daphne Koller Makes Key Hire at Insitro by Welcoming Google and Facebook VetSeptember 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: